“Pasien Pandai” Program: An Effort to Increase Adherence to Medication In Diabetes Mellitus Type 2 Patients

Authors

  • Siti Muthia Dinni Faculty of Psychology, Universitas Ahmad Dahlan

DOI:

https://doi.org/10.12928/jehcp.v5i2.5401

Abstract

Abstract

 

Diabetes Mellitus type 2 (DM 2) is a type of chronic disease that is essentially incurable. The only possible effort for health maintenance is self-management to keep blood glucose levels normal. Although adherence to medication arrangements is important for patients, their tendency to comply is relatively low. Having seen this problem, there is a need for a psychological intervention that is focused on the growth of acceptance, strengthens commitment for a change, and facilitates behavioral change. The “Pasien PANDAI†(Patients with Acceptance and Action) Program was designed integratively to accommodate the stated three focuses. A Quasi-Experiment with The One-Group Pretest-Posttest Design was defined as the study design. The subjects of the experiment were five members Persadia (Diabetes Association of Indonesia), Yogyakarta branch. Data Analysis was done with Wilcoxon Signed Rank Test and descriptive analysis. Research results indicate that “Pasien PANDAI†Program cannot increase adherence to medication in DM 2 patients (Z = -1,826 ; p > 0,05) with constant results up until follow-up (Z = -0,535 ; p > 0,05). However, descriptive analysis shows that DM 2 still feels certain benefits from the program.

 

Keywords: Program pasien pandai, acceptance, commitment, action, diabetes mellitus, chronic  disease, adherence to treatment.

Downloads

How to Cite

Dinni, S. M. (2016). “Pasien Pandai” Program: An Effort to Increase Adherence to Medication In Diabetes Mellitus Type 2 Patients. Journal of Educational, Health and Community Psychology, 5(2), 31–46. https://doi.org/10.12928/jehcp.v5i2.5401

Issue

Vol 5 No 2 August 2016

Section

Articles

License

JEHCP used CC BY SA for copyright issues. This license lets others remix, tweak, and build upon your work even for commercial purposes, as long as they credit you and license their new creations under identical terms. This license is often compared to copy-free and open-source software licenses. All new works based on yours will carry the same license, so any derivatives will also allow commercial use. This is the license used by Wikipedia and is recommended for materials that would benefit from incorporating content from Wikipedia and similarly licensed projects.